R079
R079 (compound 17) is a selective, orally active Nrf2 activator. R079 increases Nrf2 translocation activity (EC50 = 32.41 μM) . R079 can neutralize excess levels of reactive oxygen species through activating Nrf2. R079 has anti-inflammatory properties and can be used in multiple sclerosis research [1].
Product Specifications
CAS Number
2115659-62-4
UNSPSC
12352005
Target
Keap1-Nrf2
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/r079.html
Solubility
10 mM in DMSO
Smiles
O=S(/C=C/N1C(N(C=N1)C)=O)(C2=CC=CC=C2)=O
Molecular Formula
C11H11N3O3S
Molecular Weight
265.29
References & Citations
[1] Simon J. Shaw, et al. Tuning the Reactivity of Nuclear Factor Erythroid 2 Related Factor 2 (Nrf2) Activators for Optimal in Vivo Efficacy. ACS Medicinal Chemistry Letters . 2023, Article ASAP.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6765205 3x 1.0 µg
Phlpp1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
AMM13392V 100 µL
ATXN7L1 Mouse Monoclonal Antibody [Clone ID: LBI4F6]
Sign In for Pricing
View Details